Factory Supply Bulk Tauroursodeoxycholate Tudca/Tauroursodeoxycholic Acid Powder CAS14605-22-2

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >99%
• Model NO.: 14605-22-2
• Product Name: Tauroursodeoxycholic Acid
• CAS No.: 14605-22-2
• Mf: C26h45no6s
• Shelf Life: 24 Months When Properly Stored
• The Content of Active Substances: 99%
• Supply Type: OEM/ODM
• Transport Package: Dry and Cool
• Specification: 1kg/Aluminum Foil Bag, 25kg/Cardboard Drum
• Trademark: Gina
• Origin: Shaanxi, China
• Production Capacity: 10000 Kilogram/ Month

Product Description

What is Tauroursodeoxycholic acid?

Tauroursodeoxycholic acid (TUDCA) is an ambiphilic bile acid. It is the taurine conjugate form of ursodeoxycholic acid (UDCA). Humans are found to have trace amounts of TUDCA. Ongoing research is finding TUDCA has diminishing apoptotic effects, with potential application in heart disease, Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis and stroke. Recently, TUDCA has been found to have protective effects in the eye, especially concerning retinal degenerative disorders.
 

Product Name	Tauroursodeoxycholic Acid(TUDCA) CAS NO 14605-22-2
CAS NO.	14605-22-2 TUDCA
MF	C26H45NO6S
EINECS	1308068-626-2
Melting point	173-175°C
Density	1.216±0.06 g/cm3

Function of Tauroursodeoxycholic acid
 

TUDCA has been found to have protective effects in the eye, especially concerning retinal degenerative disorders.

Application of Tauroursodeoxycholic acid

Tauroursodeoxycholic acid (TUDCA) is an ambiphilic bile acid. It is the taurine conjugate form of ursodeoxycholic acid (UDCA). Humans are found to have trace amounts of TUDCA. Ongoing research is finding TUDCA has diminishing apoptotic effects, with potential application in heart disease, Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis and stroke. Recently, TUDCA has been found to have protective effects in the eye, especially concerning retinal degenerative disorders.